ArticleFrontiers in oncology2025
Lessons learned in 20 years of endoscopic endonasal surgery for pterygopalatine and infratemporal fossae lesions: analysis of a patient series and systematic review of literature.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Novel Single-Stage Transcervical Submandibular Approach for a Giant Multicompartmental Pterygopalatine Fossa Schwannoma: A Case Report and Surgical Strategy.Cancer management and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recently, the endoscopic endonasal approach (EEA) has been proposed as a possible surgical option for benign and malignant tumors, located in the infratemporal (ITF) and pterygopalatine fossae (PPF). The aim of this study is to analyze the surgical outcome of the EEA for these lesions, identifying the preoperative factors affecting tumor resection. Materials and methods: All consecutive cases of PPF and ITF tumors operated through an EEA have been retrospectively collected. Preoperative clinical and radiological features, surgical outcome, complications and patient follow-up have been analyzed. A systematic review of literature has been performed. Results: The series includes 100 patients (66 males, 66.0%, mean age: 43.7 ± 22.1). The most common histotypes were juvenile angiofibromas (36 cases, 36.0%), malignancies (26, 26.0%), and chordomas (14, 14.0%). Gross total resection of the PPF/ITF portion of the tumor was achieved in 88 (88.0%) patients. The most common complication was represented by 10 cases (10.0%) of V2 hypoesthesia (3 transient). At logistic regression, tumor location in the temporo-masseteric and tubo-pharyngeal zones proved negatively associated with the GTR rate (p:0.05, p<0.01). Conclusion: EEA is an effective and safe approach for both benign and malignant tumors involving the PPF and ITF. It is characterized by a favorable complications rate and a quick patients recovery. We observed that the tumor extensions in the temporo-masseteric area and in the tubo-pharyngeal space were the most relevant factors negatively associated with complete tumor removal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.